Yu, S.

patient stent vessel spirit artery study spirit ii lesion restenosi trial group analysis randomized angiographic signi ficantly signi in-stent diameter infarction target artery disease ees group intervention difference xience paclitaxel-eluting everolimus-eluting stent vessel patients randomized 10.1002/ ccd spirit iii outcome xience v ees disease ficantly everolimus-eluting cardiol table paclitaxel-eluting stent result vessel size signi ficant difference follow-up signi ficant reduction sirolimus-eluting xience v vs implantation reference vessel diameter in-segment ees patients behalf non-q-wave abbott 1 year sirolimus-eluting stents event investigator ficant angiographic restenosis research polymer comparison catheterization angiography 10.1002/ reference month serruy drug-eluting neumann fj popma jj table ii des implantation spirit iii studies van domburg rt characteristic vessel disease bartorelli pes patients 6 months æsd in-stent mld